Global Stock News

Cortexyme: A Challenging Path Forward

Article feature image

Cortexyme: A Challenging Path Forward

ThitareeSarmkasat/iStock via Getty Images
Cortexyme’s hypothesis is that a neurological infection with P. gingivalis (Pg) is a cause of Alzheimer’s disease (AD). The GAIN trial enrolled mild to moderate Alzheimer’s patients but required no proof that patients…

Click here to view the original article.

Share this article

Scroll to Top